| NMD NEUROMUSCULAR DISORDERS NMD Pharma A/S
79238591 18 May 2018 | on 23 Jul 2019
| Scientific and technological services and research, namely, research i... Class 005 Class 005 Pharmaceutical Products "NEUROMUSCULAR DISORDERS" Class 042 Class 042 Computer & Software Services & Scientific Services Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care | | | NMD PHARMA NEUROMUSCULAR DISORDERS NMD Pharma A/S
79238525 18 May 2018 | on 23 Jul 2019
| Scientific and technological services and research, namely, research i... Class 005 Class 005 Pharmaceutical Products "PHARMA" AND "NEUROMUSCULAR DISORDERS" Class 042 Class 042 Computer & Software Services & Scientific Services Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care | | 
